New
We are pleased to announce that John E. Harris, M.D., Ph.D., a distinguished vitiligo investigator from University of Massachusetts, was awarded with a grant by Dermatology Foundation to continue research on Skin-Resident Memory T Cells in Vitiligo. Last year, VRF has supported John Harris' project that aims to test some new substances for vitiligo treatment using his unique mouse model of vitiligo. If successful, this could be a critical step towards developing a new approach to vitiligo treatment.
FAQOther Questions
- Is there a traditional medicine to treat vitiligo?
Traditional medicines may be helpful in chronic, metabolic, and stress-related conditions early in the disease manifestation, before extensive tissue and organ damage has occurr...
- Which therapy has minimal side-effects?
Dead Sea climatotherapy has shown promising results and top safety profile in treating vitiligo in people of all ages. It is considered as the only treatment that’s safe for nea...
- Is vitiligo contagious?
Vitiligo is NOT contagious. It cannot be passed on or caught from touching someone with vitiligo, shaking hands, swimming in the same pool, sharing towels, sitting next to someo...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.